Wellness Clinical Research LLC

A concentrated screening workload needs a prepared team. Before this Phase 3 obesity-with-diabetes study began, WCR added staff and engaged potential participants through the investigator’s practice. 27 participants screened within the first month after activation. Thirteen subsequently randomized, approximately one month after screening. See how staffing, early outreach, and appointment coordination supported execution.

Evaluating Miami Lakes, Puerto Rico, or both? Work with one coordinated research organization connecting local investigators, site teams, recruitment, and operations. WCR brings the relevant teams into the conversation, with clear responsibilities and coordinated follow-up as study needs change. Let’s review where your next study fits.

Before you select your next site, look at the participant completion record. WCR’s case studies document: • Phase 1/2 influenza immunization: 47 of 47 randomized participants completed approximately one year of participation and follow-up. • Phase 3 atopic dermatitis: 100% participant completion. • Phase 2 celiac disease: all 8 randomized participants completed a protocol involving a gluten challenge, diaries, and repeated visits. Recruitment performance matters, too. In our Phase 3 obesity study, 20 of 22 screened participants randomized: 90.9% conversion. Explore the early expectation setting, ongoing relationships, and practical support behind these results. 11 case studies. Six therapeutic areas. Study-specific evidence for your next site-selection conversation. Results reflect individual studies. Future outcomes vary.

Does your next protocol require intensive sampling, infusion support, or extended observation? WCR brings clinical teams, PK collection, sample processing, and monitored storage into the site evaluation conversation. Share your procedures and visit schedule. We’ll review staffing, equipment, and capacity against your protocol.

A monitoring visit ends. The follow-through continues. At Wellness Clinical Research, findings stay connected to responsible team members, documented actions, and evidence reviewed before closure. For sponsors and CROs, that means a clear process for addressing outstanding items throughout study conduct.

Place your study in South Florida, Puerto Rico, or both — through one coordinated research organization. Phase I–IV at both locations, 10 investigators, English & Spanish teams, and private-practice patient access